Adaptimmune Therapeutics PLC: Adaptimmune to Participate in the Guggenheim Securities SMID Cap Biotech Conference February 6, 2025

Philadelphia, Pennsylvania and Oxford, United Kingdom–(Newsfile Corp. – January 30, 2025) – Adaptimmune Therapeutics plc (NASDAQ: ADAP), a company working to redefine the treatment of solid tumor…

Weiterlesen auf der Quellseite

Ähnliche Beiträge